pharmaphorum3d
CHMP calls in advisors to assist in Leqembi review
The Scientific Advisory Group (SAG) has been called in to assist the EMA’s CHMP human medicines committee ... for a SAG meeting is “a commonly used procedure for new treatments and new ...
Yahoo Finance1mon
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP ...
Zacks.com on MSN5mon
Novartis Gets CHMP Recommendation for Kisqali in Broader Population
The CHMP adopted a positive opinion for the marketing authorization for Kisqali for the adjuvant treatment of adults with ...
Yahoo Finance7d
TREMFYA® (guselkumab) receives positive CHMP opinion for treatment of patients with moderately to severely active Crohn’s Disease
“Today’s positive opinion by the CHMP marks an important step forward in offering a potentially new and differentiated treatment option for people living with this chronic and debilitating ...
Mena FN1mon
The Committee For Medicinal Products For Human Use (CHMP) Reaffirms Positive Opinion For Lecanemab In Early Alzheimer's Disease
(MENAFN- JCN NewsWire) The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion ... (5) The Pharma Letter. 2024. Brief - Alzheimer drug Leqembi now approved in China.
Nasdaq1mon
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
Viehbacher, "Biogen") announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti ...